semaglutide approval date BREAKING: The FDA has approved the first oral GLP-1 pill for obesity, marking a major milestone in the weight-loss drug market and a potential inflection point for treatment access. The daily pill US FDA accepts Novo Nordisk's

Most protocols suggest: 46 weeks on 13 weeks off before resuming if needed This cycling approach allows healing to continue naturally and may preserve long-term peptide sensitivity

GLP-1 GLP-1 (, POMC) Y(NPY) (AgRP)

Glutathione c gy ra tc dng ph khng

Low-Dose HCG (Pregnyl, HCG 10,000IU) Please disregard the printed instructions on the box of HCG This medication should be prepared and administered as follows

The glucagon arm is what distinguishes it from every GLP-1 and dual-agonist compound it increases energy expenditure in addition to the appetite and glycemic effects of the incretin receptors ( Coskun et al., Cell Metab 2022 )